Pharmacokinetics of arsenic trioxide (As2O3) in Chinese primary hepatocarcinoma patients

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 1, 2011, Pages 61-65

  Hua, Haiqing ^a,b   Qin, Shukui ^b   Rui, Jianzhong ^c   Li, Jinheng ^c  

^a NANJING GENERAL HOSPITAL OF NANJING MILITARY COMMAND   (China)

^b Chinese PLA Cancer Center   (China)

^c JINLING HOSPITAL   (China)

Author keywords

Arsenic trioxide; Chinese patient; Pharmacokinetics; Primary hepatocarcinoma treatment

Indexed keywords

EID: 79958712608     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Chen GQ, Shu J, Shi XG, et al. (1996). In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with down regulation of bcl-2 expression and alteration of PML RARa/PML protein localizaton. Blood, 88, 1052-61.
2. Chen H, Qin SK, Pan QS, et al. (2000). Antitumor effect of arsenic trioxide on mice experimental liver cancer. Chin J Hepatol, 8, 27-9.
3. Hao JH, Yu M, Li Q, et al. (2004a). An experimental study on induction of human hepatocellular carcinoma cell line apoptosis by arsenic trioxide. Chin J Hepatobiliarv Surg, 10, 414-6.
4. Hua HQ, Qin SK, Chen HY, et al. (2004b). Effect of arsenic trioxide on vascularization of tumor. World Chinese J Digestol, 12, 27-32.
5. Hua HQ, Qin SK, Wang JH, et al. (2004c). Study on effect of arsenic trioxide on adhesion and invasion of human hepatocarcinoma cells in vitro. Zhongguo Zhong Xi Yi Jie He Za Zhi, 24, 922-5.
6. Huang JF, Tan B, Wei Q, et al. (2005). Anti-hepatocarcinoma effect of arsenic trioxide on rat liver cancers induced by 2-acetamidofluorene. Chin J Hepatol, 13, 623-5.
7. Mervis J. (1996). Ancient remedy performs new tricks. Science, 273, 578.
8. Ni JH, Chen GQ, Shen ZX, et al. (1997). Pharmacokinetics of intravenous arsenic trioxide in the treatment of acute promyelocytic leukemia. Chinese J Hematol, 18, 250-3.
9. Qian J, Qin SK, He ZM, et al. (2002). Arsenic trioxide for the treatment of medium and advanced primary liver cancer. Chin J Hepatol, 10, 63.
10. Qin SK, Chen H, Pan QS, et al. (1998). An experimental study on induction of human hepatocellular carcinoma cell line apoptosis by arsenic trioxide. Chinese Clin Oncol, 3, 40.
11. Shen ZX, Chen GQ, Ni JH, et al. (1997). Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells. Blood, 89, 3354-60.
12. Zang P, Wang SY, Hu B, et al. (2000). Seven years' summary report on the treatment of acute promyelocytic leukemia with arsenic trioxide-an analysis of 242 cases. Chinese J Hematol, 21, 67-70.
13. Zhang X, Wang PL, Tao XH. (2004). Study on arsenic trioxide induced apoptosis in hepatocarcinoma cells and its molecular mechanism. J Chongqing Med University, 29, 444-7.